Anti-DLL4 VNAR targeted nanoparticles for targeting of both tumour and tumour associated vasculature
| dc.contributor.author | Leach, Adam | |
| dc.contributor.author | Smyth, Peter | |
| dc.contributor.author | Ferguson, Laura | |
| dc.contributor.author | Steven, John | |
| dc.contributor.author | Greene, Michelle K. | |
| dc.contributor.author | Branco, Cristina M. | |
| dc.contributor.author | McCann, Aidan P. | |
| dc.contributor.author | Porter, Andrew | |
| dc.contributor.author | Barelle, Caroline Jane | |
| dc.contributor.author | Scott, Christopher J. | |
| dc.contributor.institution | University of Aberdeen.Medical Sciences | en |
| dc.date.accessioned | 2020-07-22T13:15:07Z | |
| dc.date.available | 2020-07-22T13:15:07Z | |
| dc.date.issued | 2020-07-21 | |
| dc.description | Acknowledgements The authors acknowledge the Engineering and Physical Sciences Research Council (EPSRC) (S3802ASA) and the generous support of the Martin Family Foundation for funding the Ph.D. studentships of P. S. and A. L., respectively. This work was also partially funded through a US-Ireland R&D Partnership grant awarded by HSCNI (STL/5010/14), Medical Research Council UK (MC_PC_15013), and the Biotechnology and Biological Sciences Research Council (BBSRC) (BB/R009112/1). | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 13 | |
| dc.format.extent | 3420910 | |
| dc.identifier | 171742009 | |
| dc.identifier | d09212ef-7246-4692-83e3-1f69a3f153d3 | |
| dc.identifier | 85088264245 | |
| dc.identifier.citation | Leach, A, Smyth, P, Ferguson, L, Steven, J, Greene, M K, Branco, C M, McCann, A P, Porter, A, Barelle, C J & Scott, C J 2020, 'Anti-DLL4 VNAR targeted nanoparticles for targeting of both tumour and tumour associated vasculature', Nanoscale, vol. 12, no. 27, pp. 14751-14763. https://doi.org/10.1039/D0NR02962A | en |
| dc.identifier.doi | 10.1039/D0NR02962A | |
| dc.identifier.iss | 27 | en |
| dc.identifier.issn | 2040-3364 | |
| dc.identifier.uri | https://hdl.handle.net/2164/14759 | |
| dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85088264245&partnerID=8YFLogxK | en |
| dc.identifier.vol | 12 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Nanoscale | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | R Medicine | en |
| dc.subject | General Materials Science | en |
| dc.subject | Engineering and Physical Sciences Research Council (EPSRC) | en |
| dc.subject | S3802ASA | en |
| dc.subject | Medical Research Council (MRC) | en |
| dc.subject | MC_PC_15013 | en |
| dc.subject | Other | en |
| dc.subject | STL/5010/14 | en |
| dc.subject | Biotechnology and Biological Sciences Research Council (BBSRC) | en |
| dc.subject | BB/R009112/1 | en |
| dc.subject | Supplementary Data | en |
| dc.subject.lcc | R | en |
| dc.title | Anti-DLL4 VNAR targeted nanoparticles for targeting of both tumour and tumour associated vasculature | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
